Rankings
▼
Calendar
ONC FY 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$33B
FY 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$5.3B
+40.2% YoY
Gross Profit
$4.7B
87.5% margin
Operating Income
$447M
8.4% margin
Net Income
$287M
5.4% margin
EPS (Diluted)
$32.89
Cash Flow
Operating Cash Flow
$1.1B
Free Cash Flow
$942M
Stock-Based Comp.
$511M
Balance Sheet
Total Assets
$8.2B
Total Liabilities
$3.8B
Stockholders' Equity
$4.4B
Cash & Equivalents
$4.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.3B
$3.8B
+40.2%
Gross Profit
$4.7B
$3.2B
+45.3%
Operating Income
$447M
-$568M
+178.7%
Net Income
$287M
-$645M
+144.5%
← Q4 2024
All Quarters
Q1 2025 →